Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Apostolos Pappas (Athens, Greece), Apostolos Pappas, Sofia Magkouta, Maria Vazakidou, Ioannis Kalomenidis. Role of tumor derived versican in experimental malignant pleural mesothelioma. Eur Respir J 2016; 48: Suppl. 60, 496

Member's Comments

No comment yet.

Related content which might interest you: Solitary fibrous tumour of the pleural: Two malignant cases Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 A conditional contribution of mast cells to malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 A requirement for kras signaling in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree? Source: Annual Congress 2013 –Morphologic imaging Year: 2013 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 A myeloid NF-κbeta response in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Malignant pleural mesothelioma: Current status and future projections in Turkey Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Pleural mesothelioma: Our experience in 132 cases Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014